The Next Ozempic? Tufts’ 4-in-1 Weight Loss Drug Could Redefine Obesity Treatment
Weight loss science is entering a new era. For years, drugs like Ozempic and Wegovy have transformed how doctors treat…
Weight loss science is entering a new era. For years, drugs like Ozempic and Wegovy have transformed how doctors treat…
Eli Lilly’s experimental once-daily pill, orforglipron, has shown promising Phase 3 trial results, helping over 3,000 adults lose an average…
We all know our birthday, the day that marks our chronological age. But what if your body is aging at…
Early History and Evolution of Obesity Ancient Existence: Evidence of obesity dates back over 25,000 years, as depicted in Stone…
As demand for weight-loss medications like Wegovy (semaglutide) and Zepbound (tirzepatide) skyrockets, a growing number of Americans are bypassing traditional healthcare systems and turning…
More than 70 million American adults—equally split between 35 million men and 35 million women—are classified as obese. Additionally, 99…
In the world of modern healthcare, there’s a new term that’s creating waves: Diabesity. Coined to capture the dual epidemic…